LETICIA GONZALEZ: Open Payments
NPI 1316161664 · CUDAHY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,329 in 89 payments from 21 companies in 2025. Trend: 2023 $741 · 2024 $1,787 · 2025 $2,329
Food & beverage: $2,319Education: $10
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 22 | $452 |
| ABBVIE INC. | 14 | $281 |
| Lilly USA, LLC | 6 | $238 |
| Ardelyx, Inc. | 9 | $222 |
| Sumitomo Pharma America, Inc. | 6 | $202 |
| Dexcom, Inc. | 1 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $142 |
| AstraZeneca Pharmaceuticals LP | 1 | $123 |
| Novo Nordisk Inc | 4 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
Products named: VRAYLAR, IBSRELA, GEMTESA, JARDIANCE, EVENITY, Dexcom G6 Transmitter, OTEZLA, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
